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INTRODUCTION
Persons with mild Traumatic Brain Injury (mTBI) can have neuropsychological, emotional, and psychosocial changes despite a minimal loss of consciousness (Gasquoine, 1997) , with the most important problem in sustained attention and concentration (Lezak, 1995) . Changes in auditory (Gronwall, 1989) and visual (Gentilini, Nichelli, & Schoenhuber, 1989 ) sustained attention were described in separate reviews. Most recently, adults diagnosed with either mTBI or Attention Deficit Hyperactivity Disorder, inattentive subtype (American Psychiatric Association, 1994) showed significant changes in sustained attention on the Intermediate Visual and Auditory (IVA) Continuous Performance Test (CPT) (Tinius, 2000) .
Research found significant Quantitative Electroencephalography (QEEG) differences between adolescent males with ADHD (Mann, Lubar, Zimmerman, Miller, & Muenchen, 1990 ) and in adults with mTBI (Thatcher, Walker, Gerson, & Geisler, 1989) and normals. Given these changes in attention and EEG in persons with mTBI and ADHD, EEG biofeedback or neurotherapy was used for treatment. Changes after treatment with EEG biofeedback were reported in adolescents with ADHD (Lubar & Lubar, 1984) and EEG biofeedback was found to be as effective as stimulant medication in adolescents with ADHD (Rossiter & La Vaque, 1995) . For persons with mTBI, treatment with EEG biofeedback showed significant changes in several case studies (Byers, 1995; Ayers, 1993) . The purpose of this study was to measure the changes in adults diagnosed with mTBI or ADHD who were treated with EEG biofeedback in combination with cognitive retraining compared to a control group that did not receive training. It was hypothesized that scores for sustained attention would be less in the mTBI and ADHD group before treatment and would significantly increase as a result of treatment. It was also hypothesized that a self report of symptoms in the treatment groups would decrease as a result of treatment.
METHOD Participants
There were forty-four individuals (seventeen males, twenty-seven females) in this study. The control group consisted of fifteen individuals (eight males, seven females) from the local community recruited to participate in the study. The control group was screened and had a negative history of neurological and neuropsychological problems. The mild traumatic brain injury group consisted of sixteen individuals (five males, eleven females) referred for a neuropsychological evaluation and received a diagnosis of mild traumatic brain injury (mTBI) through interview, history, and neuropsychological tests. Participants in the mTBI group met the criteria of loss of consciousness of less than thirty minutes, post-traumatic amnesia of less than twenty-four hours, and/or feeling dazed or stunned at the time of injury (Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American College of Rehabilitation Medicine, 1993) . The ADHD group consisted of thirteen individuals (four males, nine females) referred for a psychological evaluation and received a diagnosis of ADHD, inattentive type by achieving 6 of 9 criteria for inattention in DSM-IV (APA, 1994) . The demographic data of the control, mTBI, and ADHD groups is shown in Table 1 .
Procedure
All individuals in the study completed the Intermediate Visual and Auditory (IVA) CPT (Sandford & Turner, 1995) , the Neuropsychological Impairment Scales (NIS; O'Donnell, DeSoto, Desoto, & Reynolds, 1984) , the Wechsler Adult Intelligence Scale-Revised (WAIS-R; Wechsler, 1981) and the Wisconsin Card Sorting Test (WCST; Heaton, Chelune, Talley, Kay, & Curtiss, 1993) pre-and post-treatment. For the mTBI and ADHD groups, treatment usually lasted for twenty sessions, but the goal was to complete treatment as quickly as possible. Clinical experience with several cases showed that twenty sessions could be an optimal stopping point. Three individuals in the ADHD group completed treatment in less than twenty sessions due to termination of insurance benefits. The control group was tested on two separate occasions approximately three to seventeen weeks apart and did not receive any treatment. All testing was completed in accordance with the standardized procedures outlined in the administration manuals.
All individuals in the mTBI and ADHD groups completed simultaneous EEG biofeedback and cognitive retraining during the treatment sessions. (Thatcher, 1987) . The treatment decisions are shown in Table 2 . The electrode placement and type of feedback for each person in the treatment groups are shown in Appendix 1. The electrode placement could change in a session given the current symptoms and performance from the previous session. The treatment sessions were tailored to the individual symptoms, pre-treatment testing, and performance in previous sessions. Each individual completed visual cognitive training exercises (Sandford, Browne, & Turner, 1993) and auditory cognitive training exercises (Sandford & Turner, 1996) on a separate computer at the same time as they received the auditory and visual EEG biofeedback. Most exercises on the visual tasks were presented for two minutes. Tasks could be repeated depending upon the person's performance and interest level. Other computer card games were used to promote problem solving, short-term memory, and attention. The cognitive retraining exercises were used to teach basic attention skills of inhibition, speed of responding, and consistency of responding visual cognitive training exercises (Sandford, Browne, & Turner, 1993 ) and auditory cognitive training exercises (Sandford & Turner, 1996) . The goal of each session was to increase task accuracy with immediate feedback, increase dual processing (auditory and visual feedback) and present multiple tasks in which the individual could experience and understand their deficits and work to overcome the deficits as quickly as possible. Throughout treatment, the computer was used to teach inhibition of impulsivity and increase accuracy of responding on tasks that require a quick accurate response. During initial treatment sessions, accuracy of responding was stressed to increase inhibition and quick decisions on tasks. After accuracy was high, speed of responding with high accuracy was trained with many different tasks.
Test Instruments:
The NIS is 72-item, self-report scale. It has 3 validity scales of Defensiveness, Affective, and Inconsistency, 3 summary scales of General Measurement of Impairment (GMI) (total of 5 symptom scales), Total Items Checked (TIC), and Symptom Intensity Measure (SIM) (Global Measure of Impairment/Total Items Checked), and 6 symptom scales of Critical Neurological Items, Cognitive Efficiency, Attention, Memory, Frustration Tolerance, Language-Verbal Learning, and Academic problems. Subjects were asked to rate the severity of problems described by items on a scale of 0 = Not At All, 1 = A Little Bit, 2 = Moderately, 3 = Quite A Bit, and 4 = Extremely.
The WCST is a card sorting neuropsychological test in which the person must determine the underlying principles and change their responses accordingly based upon feedback. The WCST was presented and scored on a 386 IBM compatible computer. The IVA test was completed on a 386 IBM compatible computer. Subjects were seated in front of the VGA computer monitor about 37.5 to 60 centimeters away from the screen. The center of the monitor was an inch or two below eye level. An ergonomic two-button mouse was placed in front of the computer screen and the left button was used to record responses. The subject's arm was allowed to rest on the table in a comfortable position. The visual stimuli (one or two) were green in color, 3.75 centimeters high and presented for 167 milliseconds (ms) inside a rectangle positioned in the middle of the computer screen. The auditory stimuli (one or two) were presented with Sony model 30 headphones attached to an 8-bit Sound Blaster card and lasted for 500 milliseconds (ms). The rectangle on the computer screen was blank during auditory presentation. The response result of each stimulus was saved on the computer for analysis. During analysis, IVA raw score variables for subjects in the control, mTBI and ADHD groups were converted to standard scores (M = 100 and SD = 15) based upon the normative data from the IVA.
Task instructions for the IVA were presented on the computer. In the warm-up part of the test, the subject was instructed by the voice on the computer to click the mouse when he or she saw a ''1.'' Next, the subject was instructed by the voice on the computer to click the mouse when he or she heard a ''1'' for ten trials. For practice trials, the subjects were instructed and given a demonstration that they would see or hear a ''1'' or a ''2.'' They were instructed to click the mouse when they saw or heard a ''1'' (target) and not click the mouse when they saw or heard a ''2'' (error) for ten trials. In the main part of the test, RT was collected on five blocks of 100 trials (500 trials total) and lasted approximately thirteen minutes. Consistent with the warmup, each subject was instructed to click the mouse when they saw or heard a ''1'' (target) and not click the mouse when they saw or heard a ''2'' (error). During the first fifty trials of a one hundred trial block, the target was presented on forty-two of the trials (84%) and the error on eight trials (16%) for a target to error ratio of 5.25 to 1. In the second fifty trials of the one hundred trial block, the target was presented on eight of the trials (16%) and the error on forty-two trials (84%) with a target to error ratio of 1 to 5.25. The presentation of visual and auditory stimuli were equally balanced in each one hundred trial block. After the five hundred trials, the cool-down part of the test was completed. This was identical to the warm-up previously described. The entire IVA test lasted about twenty minutes to complete instructions, warm-up, main test, and cool-down.
RESULTS
The correlations of change scores (Post-Treatment − Pre-Treatment) of the IVA Full Scale Attention Quotient (FSAQ) and NIS General Measure of Impairment (GMI) for the control (r = −.41), mTBI (r = .06) and ADHD (r = −.17) groups were not significant (all p's > .05). The correlation between change scores (Post-Treatment minus Pre-Treatment) of the IVA FSAQ and Full Scale Response Control Quotient (FSRQ), WAIS-R Full Scale Intelligence Quotient (FSIQ) and NIS GMI and demographic variables of number of sessions, days between testing, age, and education did not show a significant relationship among the groups (all p's > .05), and demographic variables were not included in further analysis. For groups of dependent variables, a Multivariate Analysis of Variance (MANOVA) mixed design was used for analysis with Group (Control, mTBI, ADHD) as a between subjects factor and Treatment (Pre, Post) as a within subjects factor. The multivariate Group by Treatment Interaction of the MANOVA described significant changes due to treatment in the dependent variables and significant univariate Group by Treatment Interactions. Post hoc comparisons with the Bonferroni T-test was used with an alpha level of p < .05.
The MANOVA for IVA summary scales of FSAQ, FSRQ, Hyperactivity, and Balance found a significant multivariate Group by Treatment Interaction (f = 2.77, df = 8,76, p = .01). The univariate analysis of FSAQ (f = 5.76, df = 2, 42, p < .006) and FSRQ (f = 6.40, df = 2, 42, p < .004) were significant. For the FSAQ and FSRQ interactions shown in Table 3 , post hoc Bonferroni T-test results found that at pre-treatment the mTBI and ADHD groups scored significantly less than the control group while at post-treatment there was no difference between groups. Further, the mTBI and ADHD groups showed significantly higher scores at post-treatment compared to pre-treatment, while the control group did not change. The MANOVA for IVA secondary scales of Auditory Attention Quotient (AAQ), Visual Attention Quotient (VAQ), Auditory Response Control Quotient (ARCQ), and Visual Response Control Quotient (VRCQ) found a significant Group by Treatment Interaction (f = 2.09, df = 8,76, p < .04 ). The univariate analysis of AAQ (f = 3.35, df = 2, 42, p < .04), VAQ (f = 3.09, df = 2, 42, p < .05), ARCQ (f = 6.29, df = 2, 42, p < .004) and VRCQ (f = 5.27, df = 2, 42, p < .009) were significant. For the AAQ, ARCQ, and VRCQ interactions, post hoc Bonferroni T-test results shown in Table 3 found that at pre-treatment the mTBI and ADHD groups scored significantly less than the control group while at post-treatment there were no differences between groups. Further, the mTBI and ADHD groups showed significantly higher scores at post-treatment compared to pre-treatment while the control group did not change. For the VAQ interaction, post hoc Bonferroni T-test results shown in Table 3 found at pre-treatment the mTBI group scored significantly less than the control group while at post-treatment there were no differences between groups. Further, the mTBI and ADHD groups showed significantly higher scores at post-treatment compared to pre-treatment while the control group did not change. The MAN-OVA IVA individual scales of Auditory Vigilance, Visual Vigilance, Auditory Focus, Visual Focus, Auditory Speed, and Visual Speed found the multivariate Group by Treatment Interaction (f = 1.49, df = 12, 72, p = .15) was not significant. The MANOVA for IVA individual scales of Auditory Prudence, Visual Prudence, Auditory Consistency, Visual Consistency, Auditory Stamina, and Visual Stamina found the multivariate Group by Treatment Interaction (f = 2.61, df = 12, 72, p < .006) was significant. The univariate analysis for Visual Prudence (f = 6.19, df = 2, 42, p < .004) and Auditory Consistency (f = 5.26, df = 2,42, p < .007) were significant. For the Visual Prudence and Auditory Consistency interactions, post hoc Bonferroni T-test shown in Table 3 Table 3 results found the mTBI group scored significantly less than the control group at pre-treatment, while at post-treatment there were no differences between groups. Further, the mTBI group showed significantly higher scores at post-treatment compared to pre-treatment while the control or ADHD groups did not change. The MANOVA for NIS validity scales (Defensiveness, Affective, Inconsistency) and summary scales (Global Measure of Impairment, Total Items Checked (TIC), and Symptom Intensity Measure) found a significant multivariate Group by Treatment Interaction (f = 3.29, df = 12, 68, p = .001 ). The univariate analysis found a significant interaction for Inconsistency (f = 18.7, df = 2, 40, p < .008), General Measure of Impairment (f = 4.73, df = 2,40, p < .01), and Total Items Checked (f = 4.78, df = 2,40, p < .01). For the Inconsistency interaction, post hoc Bonferroni T-test results shown in Table 4 found the mTBI group had significantly higher scores than the control group at pre-treatment while at post-treatment there was no difference between groups. Further, the mTBI and ADHD groups scored significantly less at post-treatment compared to pre-treatment while the control group did not change. For the GMI interaction, post hoc Bonferroni T-test results found the mTBI and ADHD groups rated more symptoms than the control group at pre-treatment while at post-treatment only the mTBI group rated more symptoms than the control group. Further, the mTBI and ADHD groups scored significantly less at post-treatment compared to pre-treatment while the control group did not change. For the TIC interaction, post hoc Bonferroni T-test results found the mTBI and ADHD groups checked more symptoms than the control group at pre-treatment while at post-treatment only the mTBI group checked more symptoms than the control group. Further, the mTBI and ADHD groups scored significantly less at post-treatment compared to pre-treatment while the control group did not change.
The MANOVA for NIS symptom scales (Critical Neurological Items, Cognitive Efficiency, Attention, Memory, Frustration Tolerance, Language-Verbal Learning, and Academic) found the multivariate Group by Treatment Interaction (f = 1.91, df = 14,66, p = .04) was significant. The univariate analysis found a significant interaction for Attention (f = 3.52, df = 2, 40, p < .03), Language/Verbal Learning (f = 6.12, df = 2, 40, p < .005), and Academic Problems (f = 4.79, df = 2, 40, p < .01). For the Attention and Academic Problems interactions, post hoc Bonferroni T-test results shown in Table 4 found the mTBI and ADHD groups rated more symptoms than the control group at pre-treatment while at post-treatment only the mTBI group rated more symptoms than the control group. Further, the mTBI and ADHD groups rated significantly fewer symptoms at post-treatment compared to pre-treatment while the control group did not change. For the Language/Verbal Learning interaction, post hoc Bonferroni T-test results shown in Table 4 found the mTBI and ADHD groups rated more symptoms than the control group at pre-treatment while at post-treatment only the mTBI group rated more symptoms than the control group. Further, only the mTBI rated significantly fewer symptoms at post-treatment compared to pre-treatment while the control group did not change. The MANOVA for WAIS-R Full Scale IQ, Verbal IQ, and Performance IQ found the Group by Treatment Interaction (f = 2.73, df = 6, 54, p < .02) was significant. The univariate analysis for FSIQ (f = 2.72, df = 2, 30, p < .08), VIQ (f < 1) and PIQ (f = 2.50, df = 2, 30, p < .09) were not significant. The MANOVA for WCST Number of Trials, Errors, Perseverative Errors, and Nonperseverative Errors found the multivariate Group by Treatment Interaction (f = 2.47, df = 8,66, p = .02) was significant. The univariate analysis found a significant interaction for Number of Trials (f = 3.99, df = 1, 37, p < .02) and Number of Perseverative Errors (f = 4.17, df = 1, 37, p < .02). For the Number of Trials and Number of Perseverative Errors interactions, post hoc Bonferroni T-test shown in Table 5 results found the mTBI group had higher scores than the control group at pre-treatment while at post-treatment the mTBI group was not significantly different from the control group. Further, the mTBI group scored significantly less at post-treatment compared to pre-treatment while the control and ADHD groups did not change.
DISCUSSION
The treatment model of simultaneously providing EEG biofeedback (neurotherapy) and cognitive retraining exercises significantly improved scores on a measure of sustained attention in individuals diagnosed with mTBI and ADHD when compared to a normal control group that did not receive treat- Perseverative Errors Pre 8.5 (6.4) 22.6 (19.9) * 10.9 (3.8) Post 7.8 (5.4) 10.4 (9.2) ** 10.6 (7.7)
* Significantly Different from Pre-Treatment Control ** Significantly Different from Pre-Treatment Score ment. Full scale sustained attention (FSAQ) and full scale response accuracy (FSRQ) of the IVA CPT was significantly less than the mTBI and ADHD groups at pre-treatment, but at post-treatment was in the normal range. The IVA secondary scales showed significant improvement after treatment for the mTBI and ADHD groups suggesting that auditory and visual modalities improve equally from treatment. The treatment effect was similar in the mTBI and ADHD groups on auditory and visual attention response accuracy scales in that both groups show a similar improvement in test scores at post-treatment. Test experience to complete the IVA and NIS and time between testing did not account for the treatment effect on sustained attention or self report of symptoms for the mTBI and ADHD groups. The changes from treatment in this model were not related to age or education. In regard to neuropsychological tests, the results of the WCST suggest that tasks related to frontal lobe functioning may be an outcome measure for treatment with EEG biofeedback or neurotherapy at least for the mTBI group. There was no significant change in intelligence scores on the WAIS-R from treatment as all three groups showed a practice effect. Intelligence scores may not be an adequate measure of change for this treatment model because of a practice effect. The individual IVA attention scales (Speed (RT), focus and vigilance) showed improvement after treatment but did not reach the level of significance. A specific individual attention scale could not account for the change in full scale and secondary scale attention, but the sum of the individual attention scales contributed to significant changes in the full and secondary scales. Individual response accuracy scales showed a decrease in visual impulsivity and an increase in auditory consistency for the mTBI and ADHD groups. The remaining individual response accuracy scales did not reach the level of significance, but contributed to the significant change in response accuracy on full and secondary scales. Another change in accuracy of responding was found on the comprehension scale of the IVA. For the mTBI group, auditory and visual comprehension scales found a significant decrease in multiple clicks and fine motor movement with the mouse during the test. At post-treatment the mTBI group but not the ADHD group showed significantly less fine motor movement and greater ability to tolerate boring tasks as a result of treatment, however the mTBI group started out lower than the ADHD group and there was more room for improvement to post-treatment scores.
The change scores (Post-Treatment minus Pre-Treatment) of the NIS GMI self-report scale and the IVA FSAQ or FSRQ scales were not correlated in each group. The NIS is a self report of symptoms over a wide range of situations and areas of functioning that includes personal perception and bias. At pre-treatment, the mTBI and ADHD groups scored higher than the control on the Inconsistency scale of the NIS, but at post-treatment all groups were similar suggesting a significantly greater consistency in self awareness of symptoms as a result of treatment. The control group showed no change on the NIS scales but the mTBI and ADHD groups showed a significant decrease in symptoms at post-treatment. The NIS items measure a self report of many situations and the decrease in scores is probably an attempt by individuals in treatment groups to generalize changes from the sessions in the office to other situations. The mTBI group scored higher on several of the NIS scales than the control group at post-treatment, while the ADHD group scored the same as the control group. The developmental and long term problems for persons in the ADHD group compared to the sudden changes for the mTBI group may allow the ADHD group to generalize the changes faster and in more situations resulting in scores that are similar to the control group at post-treatment. On the WCST, problem solving and concept formation in the mTBI group were significantly different from the control group prior to treatment and therefore, the mTBI group may take more time or trials to generalize the results of treatment.
The results suggest that EEG biofeedback and cognitive retraining maybe a viable alternative treatment option to medication for adults with mTBI and ADHD. Rossiter and La Vaque (1995) suggested that EEG biofeedback may be the treatment of choice in cases where medication is ineffective, only partially effective, has unacceptable side effects, or where compliance with taking medication is low in children with ADHD. The present results suggest a similar conclusion in regard to treatment with EEG biofeedback and cognitive retraining in adults with ADHD or mTBI. There are few reports published on the efficacy of medication with mTBI (Levin, 1991; Lozano, 1991; Maldonado, Perez & Escario, 1991; Spiers & Hochanadel, 1999) . However, methylphenidate showed a significant decrease in symptoms with ADHD (Gualtieri, Ondrusek, & Finley, 1985; Mattes, Boswell, & Oliver, 1984) . A typical psychotherapy treatment plan promotes coping skills for ADHD and mTBI. The treatment plan does not change sustained attention. A goal of this treatment model was to increase functional performance and decrease symptoms in twenty sessions or less. Previously, significant changes were shown in children with ADHD after twenty sessions (Rossiter & La Vaque, 1995) . This treatment model showed functional changes in attention and self reports of symptoms. The relationship between these changes and changes in quantitative EEG are unknown. The results are limited in the ability to define the curative aspects, parts or exercises in the mTBI and ADHD groups. Norris (1995) suggested that EEG biofeedback is one tool in treatment and may not solely account for all treatment changes. It is possible that some individuals in the treatment groups responded to the EEG biofeedback, others to the cognitive retraining, and some to the combination of both methods. A design where an individual would receive randomly or inconsistent feedback would help to assess for changes due to the relationship of the therapist. Further research comparing EEG biofeedback and cognitive retraining would be helpful to describe which elements of treatment are most beneficial in treatment groups. Outcome research of long-term changes from treatment is also needed.
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